Wednesday, May 31, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

DARPA Award to MIT for Living Foundries: 1000 Molecules

by Global Biodefense Staff
May 6, 2015

The U.S. Department of Defense has recently awarded the following notable contract related to the field of chemical, biological, radiological and nuclear (CBRN) defense or life science research of interest for potential applications in biodefense:

Massachusetts Institute of Technology, Cambridge, Massachusetts, has been awarded an $11,085,634 cost-reimbursement contract with options under the Living Foundries: 1000 Molecules program.

The goal of the program is to develop a first-of-its-kind biotechnology infrastructure that enables transformative and currently inaccessible projects to provide new materials, flexible capabilities, and manufacturing paradigms for national security and public health. As a demonstration of the functionality and flexibility of the infrastructure being developed, the program aims to generate 1000 unique molecules and chemical building blocks of relevance to DoD.

Fiscal 2014 research and development funds in the amount of $8,583,435 are being obligated at the time of award. Work will be performed in Cambridge, Massachusetts (90 percent); Boston, Massachusetts (3 percent); Evanston, Illinois (4 percent); and San Francisco, California (3 percent), with an estimated completion date of November 2016.

This contract was a competitive acquisition. The Defense Advanced Research Projects Agency, Arlington, Virginia, is the contracting activity (HR0011-15-C-0084).

Tags: AwardsDARPA

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC